Article|Articles in Press, 100861

Dominant-negative variants in CBX1 cause a neurodevelopmental disorder

Published:April 20, 2023DOI:



      This study aimed to establish variants in CBX1, encoding heterochromatin protein 1β (HP1β), as a cause of a novel syndromic neurodevelopmental disorder.


      Patients with CBX1 variants were identified, and clinician researchers were connected using GeneMatcher and physician referrals. Clinical histories were collected from each patient. To investigate the pathogenicity of identified variants, we performed in vitro cellular assays and neurobehavioral and cytological analyses of neuronal cells obtained from newly generated Cbx1 mutant mouse lines.


      In 3 unrelated individuals with developmental delay, hypotonia, and autistic features, we identified heterozygous de novo variants in CBX1. The identified variants were in the chromodomain, the functional domain of HP1β, which mediates interactions with chromatin. Cbx1 chromodomain mutant mice displayed increased latency-to-peak response, suggesting the possibility of synaptic delay or myelination deficits. Cytological and chromatin immunoprecipitation experiments confirmed the reduction of mutant HP1β binding to heterochromatin, whereas HP1β interactome analysis demonstrated that the majority of HP1β-interacting proteins remained unchanged between the wild-type and mutant HP1β.


      These collective findings confirm the role of CBX1 in developmental disabilities through the disruption of HP1β chromatin binding during neurocognitive development. Because HP1β forms homodimers and heterodimers, mutant HP1β likely sequesters wild-type HP1β and other HP1 proteins, exerting dominant-negative effects.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      ACMG Member Login

      Are you an ACMG Member? Sign in for online access.


      Subscribe to Genetics in Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Bannister A.J.
        • Zegerman P.
        • Partridge J.F.
        • et al.
        Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain.
        Nature. 2001; 410: 120-124
        • Saksouk N.
        • Hajdari S.
        • Perez Y.
        • et al.
        The mouse HP1 proteins are essential for preventing liver tumorigenesis.
        Oncogene. 2020; 39: 2676-2691
        • Machida S.
        • Takizawa Y.
        • Ishimaru M.
        • et al.
        Structural basis of heterochromatin formation by human HP1.
        Mol Cell. 2018; 69: 385-397.e8
        • Ostapcuk V.
        • Mohn F.
        • Carl S.H.
        • et al.
        Activity-dependent neuroprotective protein recruits HP1 and CHD4 to control lineage-specifying genes.
        Nature. 2018; 557: 739-743
        • Sampath S.C.
        • Marazzi I.
        • Yap K.L.
        • et al.
        Methylation of a histone mimic within the histone methyltransferase G9a regulates protein complex assembly.
        Mol Cell. 2007; 27: 596-608
        • Kleefstra T.
        • Smidt M.
        • Banning M.J.
        • et al.
        Disruption of the gene Euchromatin histone methyl Transferase1 (Eu-HMTase1) is associated with the 9q34 subtelomeric deletion syndrome.
        J Med Genet. 2005; 42: 299-306
        • Kleefstra T.
        • van Zelst-Stams W.A.
        • Nillesen W.M.
        • et al.
        Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype.
        J Med Genet. 2009; 46: 598-606
        • Weiss K.
        • Terhal P.A.
        • Cohen L.
        • et al.
        De novo mutations in CHD4, an ATP-dependent chromatin remodeler gene, cause an intellectual disability syndrome with distinctive dysmorphisms.
        Am J Hum Genet. 2016; 99: 934-941
        • Helsmoortel C.
        • Vulto-van Silfhout A.T.
        • Coe B.P.
        • et al.
        A SWI/SNF-related autism syndrome caused by de novo mutations in ADNP.
        Nat Genet. 2014; 46: 380-384
        • Weiss K.
        • Wigby K.
        • Fannemel M.
        • et al.
        Haploinsufficiency of ZNF462 is associated with craniofacial anomalies, corpus callosum dysgenesis, ptosis, and developmental delay.
        Eur J Hum Genet. 2017; 25: 946-951
        • Luo X.
        • Schoch K.
        • Jangam S.V.
        • et al.
        Rare deleterious de novo missense variants in Rnf2/Ring2 are associated with a neurodevelopmental disorder with unique clinical features.
        Hum Mol Genet. 2021; 30: 1283-1292
        • Aucott R.
        • Bullwinkel J.
        • Yu Y.
        • et al.
        HP1-beta is required for development of the cerebral neocortex and neuromuscular junctions.
        J Cell Biol. 2008; 183: 597-606
        • Sobreira N.
        • Schiettecatte F.
        • Valle D.
        • Hamosh A.
        GeneMatcher: a matching tool for connecting investigators with an interest in the same gene.
        Hum Mutat. 2015; 36: 928-930
        • Arora S.
        • Horne W.S.
        • Islam K.
        Engineering methyllysine writers and readers for allele-specific regulation of protein-protein interactions.
        J Am Chem Soc. 2019; 141: 15466-15470
        • Pettersen E.F.
        • Goddard T.D.
        • Huang C.C.
        • et al.
        UCSF ChimeraX: structure visualization for researchers, educators, and developers.
        Protein Sci. 2021; 30: 70-82
        • Shapovalov M.V.
        • Dunbrack Jr., R.L.
        A smoothed backbone-dependent rotamer library for proteins derived from adaptive kernel density estimates and regressions.
        Structure. 2011; 19: 844-858
        • Li J.
        • Shi L.
        • Zhang K.
        • et al.
        VarCards: an integrated genetic and clinical database for coding variants in the human genome.
        Nucleic Acids Res. 2018; 46: D1039-D1048
        • Ioannidis N.M.
        • Rothstein J.H.
        • Pejaver V.
        • et al.
        REVEL: an ensemble method for predicting the pathogenicity of rare missense variants.
        Am J Hum Genet. 2016; 99: 877-885
        • Karczewski K.J.
        • Francioli L.C.
        • Tiao G.
        • et al.
        The mutational constraint spectrum quantified from variation in 141,456 humans.
        Nature. 2020; 581: 434-443
        • Richards S.
        • Aziz N.
        • Bale S.
        • et al.
        Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
        Genet Med. 2015 May; 17: 405-424
        • Ellard S.
        • Baple E.L.
        • Callaway A.
        • et al.
        ACGS best practice guidelines for variant classification in rare disease 2020. Association for Clinical Genomic Science.
        (Accessed March 9, 2023)
        • Tsai M.Y.
        • Zheng W.
        • Balamurugan D.
        • et al.
        Electrostatics, structure prediction, and the energy landscapes for protein folding and binding.
        Protein Sci. 2016; 25: 255-269
        • Zhou H.X.
        • Pang X.
        Electrostatic interactions in protein structure, folding, binding, and condensation.
        Chem Rev. 2018; 118: 1691-1741
        • Li S.C.
        • Goto N.K.
        • Williams K.A.
        • Deber C.M.
        Alpha-helical, but not beta-sheet, propensity of proline is determined by peptide environment.
        Proc Natl Acad Sci U S A. 1996; 93: 6676-6681
        • Mateos-Langerak J.
        • Brink M.C.
        • Luijsterburg M.S.
        • van der Kraan I.
        • van Driel R.
        • Verschure P.J.
        Pericentromeric heterochromatin domains are maintained without accumulation of HP1.
        Mol Biol Cell. 2007; 18: 1464-1471
        • Cheutin T.
        • McNairn A.J.
        • Jenuwein T.
        • Gilbert D.M.
        • Singh P.B.
        • Misteli T.
        Maintenance of stable heterochromatin domains by dynamic HP1 binding.
        Science. 2003; 299: 721-725
        • Ricke R.M.
        • Bielinsky A.K.
        Easy detection of chromatin binding proteins by the Histone Association Assay.
        Biol Proced Online. 2005; 7: 60-69
        • Canzio D.
        • Chang E.Y.
        • Shankar S.
        • et al.
        Chromodomain-mediated oligomerization of HP1 suggests a nucleosome-bridging mechanism for heterochromatin assembly.
        Mol Cell. 2011; 41: 67-81
        • Nishibuchi G.
        • Nakayama J.
        Biochemical and structural properties of heterochromatin protein 1: understanding its role in chromatin assembly.
        J Biochem. 2014; 156: 11-20
        • Brasher S.V.
        • Smith B.O.
        • Fogh R.H.
        • et al.
        The structure of mouse HP1 suggests a unique mode of single peptide recognition by the shadow chromo domain dimer.
        EMBO J. 2000; 19: 1587-1597
        • Bian C.
        • Chen Q.
        • Yu X.
        The zinc finger proteins ZNF644 and WIZ regulate the G9a/GLP complex for gene repression.
        eLife. 2015; 4e05606
        • Ueda J.
        • Tachibana M.
        • Ikura T.
        • Shinkai Y.
        Zinc finger protein Wiz links G9a/GLP histone methyltransferases to the co-repressor molecule CtBP.
        J Biol Chem. 2006; 281: 20120-20128
        • Yelagandula R.
        • Stecher K.
        • Novatchkova M.
        • et al.
        ZFP462 safeguards neural lineage specification by targeting G9A/GLP-mediated heterochromatin to silence enhancers.
        Nat Cell Biol. 2023; 25: 42-55
        • Gao Z.
        • Zhang J.
        • Bonasio R.
        • et al.
        PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes.
        Mol Cell. 2012; 45: 344-356
        • Ye Q.
        • Callebaut I.
        • Pezhman A.
        • Courvalin J.C.
        • Worman H.J.
        Domain-specific interactions of human HP1-type chromodomain proteins and inner nuclear membrane protein LBR.
        J Biol Chem. 1997; 272: 14983-14989
        • Liu Y.
        • Qin S.
        • Lei M.
        • et al.
        Peptide recognition by heterochromatin protein 1 (HP1) chromoshadow domains revisited: plasticity in the pseudosymmetric histone binding site of human HP1.
        J Biol Chem. 2017; 292: 5655-5664
        • Thiru A.
        • Nietlispach D.
        • Mott H.R.
        • et al.
        Structural basis of HP1/PXVXL motif peptide interactions and HP1 localisation to heterochromatin.
        EMBO J. 2004; 23: 489-499
        • Peters A.H.
        • O’Carroll D.
        • Scherthan H.
        • et al.
        Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability.
        Cell. 2001; 107: 323-337
        • Nielsen P.R.
        • Nietlispach D.
        • Mott H.R.
        • et al.
        Structure of the HP1 chromodomain bound to histone H3 methylated at lysine 9.
        Nature. 2002; 416: 103-107
        • Yap K.L.
        • Zhou M.M.
        Structure and mechanisms of lysine methylation recognition by the chromodomain in gene transcription.
        Biochemistry. 2011; 50: 1966-1980
        • Ayoub N.
        • Jeyasekharan A.D.
        • Bernal J.A.
        • Venkitaraman A.R.
        HP1-beta mobilization promotes chromatin changes that initiate the DNA damage response.
        Nature. 2008; 453: 682-686
        • Parkinson J.
        • Hard R.
        • Ainsworth R.I.
        • Li N.
        • Wang W.
        Engineering a histone reader protein by combining directed evolution, sequencing, and neural network based ordinal regression.
        J Chem Inf Model. 2020; 60: 3992-4004